CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 31 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,067,000 | +3.5% | 13,000,000 | -21.2% | 0.04% | +5.0% |
| Q1 2017 | $21,326,000 | +106.5% | 16,500,000 | +65.0% | 0.04% | +90.5% |
| Q4 2016 | $10,325,000 | -10.8% | 10,000,000 | -25.7% | 0.02% | -19.2% |
| Q4 2015 | $11,570,000 | +53.6% | 13,454,000 | +199.0% | 0.03% | +44.4% |
| Q3 2015 | $7,534,000 | – | 4,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |